3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
24
Colorectal Neoplasms
19
Rectal Neoplasms
11
Stomach Neoplasms
9
Colonic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Carcinoma, Hepatocellular
7
Neoplasm Metastasis
6
Squamous Cell Carcinoma of Head and Neck
5
Neoplasms
5
Liver Neoplasms
5
Esophageal Neoplasms
5
Uterine Cervical Neoplasms
4
Urinary Bladder Neoplasms
4
Osteosarcoma
4
Cholangiocarcinoma
4
Peritoneal Neoplasms
3
Ovarian Neoplasms
3
Neuroblastoma
3
Multiple Myeloma
3
Lung Neoplasms
3
Locally Advanced Rectal Cancer
3
Kidney Neoplasms
3
Inflammatory Breast Neoplasms
3
Turcot syndrome
2
Sarcoma
2
Pancreatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Head and Neck Neoplasms
2
Glioblastoma
2
Interventions
Cyclophosphamide
16
Dexamethasone
14
Melphalan
12
Bortezomib
11
Filgrastim
6
Peripheral Blood Stem Cell Transplantation
5
Lenalidomide
5
Thalidomide
4
Prednisone
4
sargramostim
3
fludarabine phosphate
3
daratumumab
3
Radiotherapy
3
Mycophenolic Acid
3
Interferon-alpha
3
Doxorubicin
3
Busulfan
3
Antilymphocyte Serum
3
pomalidomide
2
isatuximab
2
fludarabine
2
Vincristine
2
Methylprednisolone
2
Idarubicin
2
Cyclosporine
2
Carmustine
2
plerixafor
1
pegfilgrastim
1
orantinib
1
epoetin beta
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms, Plasma Cell
×
Neoadjuvant Therapy
×
Clear all
NCT01554852
2018-06-11
Myeloma XI
University of Leeds
Phase 3
Unknown
4,420 enrolled